Corrigendum to “Development of a neurologic severity scale for Aicardi Goutières Syndrome” [Mol Genet Metab. 2020 Jun;130(2):153–160. PMID: 32279991]

Laura Adang(Children's Hospital of Philadelphia), Adeline Vanderver(Children's Hospital of Philadelphia), Kimberly Kopin(Children's Hospital of Philadelphia), Jessica Galli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Kyle Peer(Children's Hospital of Philadelphia), Stacy V. Cusack(Children's Hospital of Philadelphia), Constance Besnier(Children's Hospital of Philadelphia), Francesco Gavazzi(Children's Hospital of Philadelphia), Valentina De Giorgis(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Elisa Fazzi(Urology Foundation), Micaela De Simone(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Justine Shults(Children's Hospital of Philadelphia), Abbas F. Jawad(Children's Hospital of Philadelphia), Simona Orcesi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino)
Molecular Genetics and Metabolism
April 11, 2022
10.1016/j.ymgme.2022.03.010
Cited by 0

Related Papers

Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection
|Nature Genetics|2006|673
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies
|Nature Genetics|2009|412
Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome
|Nature Genetics|2006|402
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
|The Lancet Neurology|2020|326